Combination comprising a VEGF inhibitor and a serine protease for treating neovascular diseases

Details for Australian Patent Application No. 2007247426 (hide)

International Classifications

Event Publications

13 November 2008 PCT application entered the National Phase

PCT publication WO2007/128526 Priority application(s): WO2007/128526

25 November 2010 Alteration of Name

The name of the applicant has been altered to Fondation Ophtalmologique Adolf de Rothschild; Fovea Pharmaceuticals

29 September 2011 Alteration of Name

The name of the applicant has been altered to Fondation Ophthalmologique Adolf de Rothschild; Fovea Pharmaceuticals

8 March 2012 Application Accepted

Published as AU-B-2007247426

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.